We are Healthcare & Medical Sciences Originators.
HMO brings healthcare ventures, investments and scientific pipelines into being — from first concept to a bankable, licensed, operating business.
Originators, not administrators.
Clients don't retain us to optimise back-office administration. They retain us because we bring new ventures, structural investments and therapeutic pipelines into being — from zero.
HMO Consulting works at the interface of healthcare infrastructure and medical science. We are physician-led, which means every project is tested first on the question that sinks most healthcare deals: will it work clinically, and will it get licensed?
Founded by Dr. Hamad M. Alomar, the firm draws on more than two decades of building healthcare and life sciences companies in Saudi Arabia and abroad — and works alongside its sister company, Rifad Investments, the group's equity holder.
Three kinds of origination.
Each starts with an idea, a gap or an asset — and ends with something that exists, is funded and runs.
Deal & capital origination
Working with investors, family offices and corporate development teams to target, diligence and structure high-conviction healthcare and medtech acquisitions.
Clinical model origination
Designing, piloting and standing up new care formats — hospitals, specialty centres, clinic platforms and home healthcare — with a credible operating model from day one.
Scientific & technology origination
Turning scientific discoveries and foreign technologies into Saudi pipelines — biotech, technology transfer, localisation and international partner access.
From hospitals to biotech.
Hospitals & specialty centres
Clinical model, service mix, licensing path and international operator partners.
Bankable hospital projects with a credible operator from day one.
Specialty clinics & day surgery
Service-line selection, clinical staffing model and roll-out playbook.
Scalable platforms ready for growth capital or acquisition.
Biotech & life sciences
Scientific and technology diligence; tech-transfer and partner access through Geneva and the USA.
Investable localisation and technology-transfer deals.
Medical supply & distribution
Product and regulatory assessment; supplier and manufacturer relationships.
Consolidated, localised supply chains.
Health-tech & digital health
Clinical validation, provider adoption and regulatory fit.
Health-tech ventures backed by clinical proof.
Investors entering healthcare
Sector strategy, target screening and clinical due diligence.
A clear, de-risked entry into Saudi healthcare.
Studied. Structured. Ready for the right owner.
HMO originates healthcare ventures in-house and takes them to feasibility. We're looking for partners to execute them.
HMO has originated several studied ventures across hospitals, oncology, medical equipment, sports health and pharma retail. Qualified partners can request the portfolio under NDA.
HMO holds an interest in the opportunities it originates.
From idea to operating business.
Identify
Spot the opportunity through market insight, clinical need or an available asset.
Develop
Validate the concept, build the business model and map the regulatory path.
Structure
Shape the deal, bring in partners and capital, and set governance.
Build
Launch, appoint management and scale — with HMO alongside as needed.
Dr. Hamad M. Alomar
MD, MBA · Founder & Principal
A physician who builds companies.
Dr. Alomar has worked in the healthcare and life sciences business since 2000. His ventures include the National Blood and Cancer Center — the first centre of its kind in Saudi Arabia — as well as companies in digital health, home healthcare, medical supply and international life sciences trade.
He leads HMO Consulting on three filters: mass impact, blue ocean, and enjoyment of the work.
Let's originate something together.
Two ways to work with HMO. Choose the one that fits you.
Have a project or need advice?
For investors, health systems, family offices and founders with a healthcare or life sciences idea, asset or decision.
Become a partner
Firms: financial houses, operators, international hospitals and technology partners.
Experts: senior physicians, scientists and consultants who want to originate with us.